---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-016831"
form_type: "8-K"
ticker: "EXOZ"
cik: "0002010788"
company_name: "EXOZYMES INC."
filed_at: "2025-10-03T23:59:59+00:00"
generated_at: "2026-05-17T04:51:31.290475+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ExoZymes files updated investor presentation as of September 30, 2025

## Summary
- Investor presentation filed as Exhibit 99.1 to Form 8-K on October 3, 2025
- Presentation dated September 30, 2025, updated company materials
- Report signed by Vice President of Finance Fouad Nawaz

## SEC filing metadata
- accession: 0001493152-25-016831
- form_type: 8-K
- ticker: EXOZ
- cik: 0002010788
- company_name: EXOZYMES INC.
- filed_at: 2025-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2010788/000149315225016831/0001493152-25-016831-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2010788/000149315225016831/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-016831
- JSON: https://secwatch.observer/filing/0001493152-25-016831.json
- Plain text: https://secwatch.observer/filing/0001493152-25-016831.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.